ABBV - AbbVie's immunology drugs brought in $9.17B, up 16.3% from a year ago
So what
Skyrizi and Rinvoq grew 23% and 24%, while Humira fell 31% to $683M.
Full-size download: part of Free Access (free). The sheet above stays free to view and share.
Free Access
One free signup opens full-size downloads of every sheet and the pre-earnings pack for each earnings week. No newsletter schedule to sign up for.
Free Access is on: full-size downloads and the pre-earnings pack are open.